| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ZIOPHARM ONCOLOGY (WEK.SG) (STU: WEK)
WEK Technical Analysis
5
| As on 30th Sep 2021 WEK STOCK Price closed @ 1.58 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.54 & Strong Sell for SHORT-TERM with Stoploss of 2.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
WEKSTOCK Price
| Open | 1.63 | Change | Price | % |
| High | 1.63 | 1 Day | -0.08 | -4.82 |
| Low | 1.55 | 1 Week | 0.06 | 3.95 |
| Close | 1.58 | 1 Month | 0.21 | 15.33 |
| Volume | N/A | 1 Year | -0.64 | -28.83 |
| 52 Week High 4.78 | 52 Week Low 1.19 | ||||
STU Germany Most Active Stocks
| QIN | 0.05 | 0.00% |
| QIN | 0.05 | 0.00% |
| QIN | 0.05 | 0.00% |
| QIN | 0.05 | 0.00% |
| QIN | 0.05 | 0.00% |
| POQ | 0.00 | % |
| POQ | 0.00 | % |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
STU Germany Top Gainers Stocks
STU Germany Top Losers Stocks
| WEK Daily Charts |
WEK Intraday Charts |
Whats New @ Bazaartrend |
WEK Free Analysis |
|
|
WEK Important Levels Intraday
| RESISTANCE | 1.73 |
| RESISTANCE | 1.68 |
| RESISTANCE | 1.65 |
| RESISTANCE | 1.62 |
| SUPPORT | 1.54 |
| SUPPORT | 1.51 |
| SUPPORT | 1.48 |
| SUPPORT | 1.43 |
WEK Forecast April 2025
| 4th UP Forecast | 2.79 |
| 3rd UP Forecast | 2.4 |
| 2nd UP Forecast | 2.16 |
| 1st UP Forecast | 1.92 |
| 1st DOWN Forecast | 1.24 |
| 2nd DOWN Forecast | 1 |
| 3rd DOWN Forecast | 0.76 |
| 4th DOWN Forecast | 0.37 |
WEK Weekly Forecast
| 4th UP Forecast | 2.24 |
| 3rd UP Forecast | 2.03 |
| 2nd UP Forecast | 1.90 |
| 1st UP Forecast | 1.77 |
| 1st DOWN Forecast | 1.39 |
| 2nd DOWN Forecast | 1.26 |
| 3rd DOWN Forecast | 1.13 |
| 4th DOWN Forecast | 0.92 |
WEK Forecast2025
| 4th UP Forecast | 8.5 |
| 3rd UP Forecast | 6.28 |
| 2nd UP Forecast | 4.91 |
| 1st UP Forecast | 3.54 |
| 1st DOWN Forecast | -0.38 |
| 2nd DOWN Forecast | -1.75 |
| 3rd DOWN Forecast | -3.12 |
| 4th DOWN Forecast | -5.34 |
ZIOPHARM ONCOLOGY (WEK.SG) ( STU Germany Symbol : WEK )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
WEK Business Profile
ZIOPHARM Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing a portfolio of immuno-oncology therapies to treat patients with cancer. The company develops Sleeping Beauty platform, which is based on the non-viral genetic engineering of immune cells using a transposon/transposase system to engineer T-cells outside of the body for infusion; and Controlled IL-12 to stimulate expression of interleukin 12 or IL-12, a master regular of the immune system, in a controlled manner to focus the patient's immune system to attack cancer cells. Its product candidates include T cell receptor + T therapies to target solid tumors; chimeric antigen receptor + T cell therapies targeting CD19 for hematologic malignancies; and Ad-RTS-hIL-12 plus veledimex, a gene delivery system to regulate production of IL-12 to treat patients with recurrent glioblastoma multiforme in adults. The company has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; a patent license agreement with the National Cancer Institute; and a cooperative research and development agreement with the National Cancer Institute. ZIOPHARM Oncology, Inc. is headquartered in Boston, Massachusetts. Address: Parris Building 34, Boston, MA, United States, 02129
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service